Background and Objectives: Pathogenic variants in genes encoding spliceosomal small nuclear RNAs (snRNAs) have recently emerged as a frequent cause of neurodevelopmental disorders (NDDs), yet these non-coding genes are commonly missed by standard diagnostic pipelines.,Methods: We investigated the diagnostic contribution of targeted snRNA gene analysis in 102 patients with global developmental delay and/or intellectual disability (GDD/ID) who remained undiagnosed after karyotyping, chromosomal microarray, and exome sequencing at a single tertiary pediatric genetics center. Existing exome data were re-evaluated for RNU2-2, RNU4-2, RNU5A-1, RNU5B-1, and RNU4ATAC, and targeted deep amplicon sequencing achieving 100% coverage at >1000× depth was performed where these loci were not captured; candidate variants were confirmed and segregated by Sanger sequencing.,Results: Rare variants were identified in eight patients (7.8%), and a definitive molecular diagnosis was established in three (2.9%). One patient carried the recurrent de novo RNU4-2 n.64_65insT variant and displayed the characteristic ReNU syndrome phenotype, including microcephaly, growth failure, distinctive facial features, and corpus callosum thinning. Two patients harbored biallelic pathogenic RNU4ATAC variants: a homozygous n.16G>A variant associated with a Roifman syndrome phenotype with transient infantile hypogammaglobulinemia, and compound heterozygous n.51G>A and n.111G>A variants in an adult with severe microcephaly, a molar tooth sign consistent with a Joubert-like ciliopathy phenotype, and relapsed Hodgkin lymphoma, an association not previously highlighted in RNU4atac-opathy.,Discussion: Our findings independently replicate the diagnostic relevance of snRNA genes in an unselected, consanguinity-enriched cohort and support incorporating these loci into routine diagnostic algorithms for unexplained NDD.